Accepted answer
The honest answer is that splitting sealed vials is a logistics arrangement and splitting anything else is a manufacturing operation.
The real saving is in carriage and in unit price breaks, not in the compound itself. Carriage on a single larger consignment is typically a fraction of the sum of individual shipments, and that is where most of the arithmetic comes from.
Cost per milligram, adjusted honestly
| Step | Value | Note |
|---|
| Vial price, 10 mg nominal | £34.00 | As advertised |
| Nominal cost per mg | £3.40 | 34 ÷ 10 |
| Measured content | 9.2 mg | Independent content assay |
| Cost per actual mg | £3.70 | 34 ÷ 9.2 |
| Dead-space loss, 20 draws | 4 % | 80 µL of a 2 mL fill |
| Cost per delivered mg | £3.85 | 3.70 ÷ 0.96 |
| First vial, with £110 assay | £14.85 | Testing dominates a single vial |
Keep a written record: who contributed, what was ordered, which lot arrived, how many vials each person received and when. It resolves disputes and it is the only documentation that will exist.
Carriage costs on international consignments scale far less than linearly with weight, which is the arithmetic basis for the saving.
There is no recourse mechanism in an informal arrangement. That is the risk, and it cannot be structured away entirely.
Split sealed vials only. Anything else breaks the certificate and the closure together.
edited 28 Dec 2024 by petra_hovland — expanded the table to cover the lower concentration
7Worth adding that legal position and enforcement posture are different things. – bea_castellanos 4 months ago 8Small correction: carriage amortises across the order, which changes small-order economics entirely. – Dr_Rosalind_Achebe 5 months ago add a comment